REGENXBIO's (RGNX) CEO Ken Mills on Q3 2017 Results - Earnings Call Transcript

11/9/17

REGENXBIO Inc. (NASDAQ:RGNX)

Q3 2017 Earnings Conference Call

November 8, 2017 4:30 PM ET

Executives

Patrick Christmas – General Counsel

Ken Mills – President and Chief Executive Officer

Vit Vasista – Chief Financial Officer

Analysts

Gbolahan Amusa – Chardon

Bin Lu – Raymond James

Josh Schimmer – Evercore ISI

Ying Huang – Bank of America Merrill Lynch

Operator

Good day, ladies and gentlemen, and welcome to the REGENXBIO Third Quarter 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]

I would now like to turn the conference over to Patrick Christmas, General Counsel. You may begin.

READ FULL ARTICLE HERE

It's on us. Share your news here.

Submit your stories and articles to citybizlist today.